Chen Hu
Impact in
-
- Lung Cancer Treatments and Mutations
- Gallbladder and Bile Duct Disorders
-
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 7
-
- PI3K/AKT/mTOR signaling in cancer 4
- Co-authors
- Caiyu Lin (10 shared papers)Yubo Wang (9 shared papers)Conghua Lu (11 shared papers)Li Li (7 shared papers)Yong He (10 shared papers)Rui Han (10 shared papers)Mingxia Feng (3 shared papers)Kejun Zhang (4 shared papers)
- Journals
- Medicine (4 papers)The Bone & Joint Journal (2 papers)Carcinogenesis (2 papers)Cancer Letters (2 papers)Advanced Healthcare Materials (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Chen Hu
37 papers receiving 391 citations
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 111
- Oncology 82
- Cancer Research 38
- Epidemiology 84
- Hepatology 15
Countries citing papers authored by Chen Hu
This map shows the geographic impact of Chen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Hu more than expected).
Fields of papers citing papers by Chen Hu
This network shows the impact of papers produced by Chen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Hu. The network helps show where Chen Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 56 | |
| 2 | 2013 | 40 | |
| 3 | 2019 | 31 | |
| 4 | 2022 | 27 | |
| 5 | 2020 | 26 | |
| 6 | 2022 | 25 | |
| 7 | 2015 | 25 | |
| 8 | 2017 | 18 | |
| 9 | 2024 | 16 | |
| 10 | 2020 | 13 | |
| 11 | 2024 | 12 | |
| 12 | 2021 | 10 | |
| 13 | 2015 | 9 | |
| 14 | 2025 | 8 | |
| 15 | 2014 | 8 | |
| 16 | 2013 | 7 | |
| 17 | 2019 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2020 | 6 | |
| 20 | 2022 | 5 |
About Chen Hu
Chen Hu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Epidemiology and Surgery, having authored 41 papers that have together received 395 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Autophagy in Disease and Therapy (3 papers), HER2/EGFR in Cancer Research (2 papers), Cancer Mechanisms and Therapy (2 papers), Plant-based Medicinal Research (2 papers), Hip and Femur Fractures (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (111 citations), Oncology (82 citations), Cancer Research (38 citations), Epidemiology (84 citations) and Hepatology (15 citations). Chen Hu has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Caiyu Lin, Yubo Wang, Conghua Lu, Li Li, Yong He, Rui Han, Mingxia Feng, Kejun Zhang, Lin Jiao and Dadong Zhang. Their work appears in journals such as Medicine, The Bone & Joint Journal, Carcinogenesis, Cancer Letters and Advanced Healthcare Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.